SUBSCRIBE
SUBSCRIBE

Genentech, Inc.

NEWS
Genentech Grows on Promise of 70+ Drug Approvals
Biotech Bay
Genentech Quietly Shelves Phase II Cancer Contender
April 27, 2017
 · 
3 min read
Genentech Grows on Promise of 70+ Drug Approvals
Drug Development
Genentech Shows Off Late-Stage Hemophilia A Data
April 17, 2017
 · 
3 min read
Juno Taps Ex-Genentech Scientist to Head Up R&D at New Bay Area Office
Business
Juno Taps Ex-Genentech Scientist to Head Up R&D at New Bay Area Office
April 17, 2017
 · 
2 min read
Policy
Celltrion Healthcare Makes Move to Restrict Genentech’s Herceptin Patents in the U.S.
March 31, 2017
 · 
1 min read
What a Day! Genentech Lands FDA Approval for First Drug to Treat Severe Multiple Sclerosis
FDA
What a Day! Genentech Lands FDA Approval for First Drug to Treat Severe Multiple Sclerosis
March 29, 2017
 · 
3 min read
Genentech Grows on Promise of 70+ Drug Approvals
Drug Development
Genentech New Breast Cancer Cocktail Cuts Deaths in Phase III Study, Roche Stock Soars
March 2, 2017
 · 
2 min read
Genentech Grows on Promise of 70+ Drug Approvals
Drug Development
Merck & Co., Eli Lilly Failure Puts Alzheimer’s Drug Development Spotlight on Rival Genentech
February 28, 2017
 · 
2 min read
Policy
Genentech Fighting to Delay Amgen’s Avastin Biosimilar
February 17, 2017
 · 
1 min read
Genentech Grows on Promise of 70+ Drug Approvals
Policy
Questions Remain Over Suicide Death of Genentech Lobbyist
February 15, 2017
 · 
2 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2023 Best Places to Work
  • 2024 Best Places to Work
JOBS
IN THE PRESS
Policy
Genentech Release: FDA Grants Priority Review For Venetoclax New Drug Application
January 12, 2016
 · 
6 min read
Drug Development
Genentech Touts Hematology Data for Gazyva and Venetoclax in CLL
December 16, 2015
 · 
3 min read
FDA
Genentech Wins Accelerated Approval for Alecensa to Treat Specific Lung Cancer Patients
December 11, 2015
 · 
10 min read
Drug Development
Genentech Release: Pivotal Phase II Study Showed Nearly 80 Percent Of People With Hard-To-Treat Type Of Chronic Lymphocytic Leukemia Responded To Investigational Medicine Venetoclax
December 7, 2015
 · 
7 min read
Drug Development
Genentech Release: New Results From CLL11 Study Show Gazyva Provided People With Previously Untreated Chronic Lymphocytic Leukemia A Treatment-Free Period Of Nearly Four Years
December 7, 2015
 · 
1 min read
Biotech Bay
Genentech Release: Updated Data Showed Cotellic In Combination With Zelboraf Helped People With A Specific Type Of Advanced Melanoma Live Significantly Longer Than With Zelboraf Alone
November 23, 2015
 · 
15 min read
Business
California Life Sciences Association Adds Leaders From Genentech, Sanford Burnham Prebys Medical Discovery Institute And OncoCyte Corporation To Board Of Directors
November 23, 2015
 · 
5 min read
Business
Ophthotech Corporation Announces That Genentech, A Roche Wholly-Owned Subsidiary, Elects To Exercise Its Right To Opt-In To The Novartis Portion Of The Ophthotech / Novartis AG Ex-US Agreement For Fovista® To Treat Wet Age-Related Macular Degeneration
November 17, 2015
 · 
1 min read
Business
Genentech Partners Up with Novartis AG on Ex-U.S. Rights to Wet AMD Candidate Fovista
November 17, 2015
 · 
7 min read
FDA
FDA Green Lights Genentech’s Vemurafenib/Cobimetinib Combo for Melanoma
November 10, 2015
 · 
4 min read
Load More